☆ 4.7 Article

SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

Adaptive immunity to SARS-CoV-2 and COVID-19

Alessandro Sette et al.

Summary: The adaptive immune system, consisting of B cells, CD4(+) T cells, and CD8(+) T cells, plays varying roles in different viral infections and vaccines. Studies are showing that CD4(+) T cells, CD8(+) T cells, and neutralizing antibodies all play a part in controlling SARS-CoV-2 in COVID-19 cases, emphasizing the importance of understanding adaptive immunity in combating the disease.

CELL (2021)

Add to Collection

Article Hematology

Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing

Alfredo Mendrone-Junior et al.

Summary: This study suggests that SARS-CoV-2 IgG immunoassays (S/CO) can predict high anti-SARS-CoV-2 nAbs titers. Different criteria for identifying donors with >= 1:160 nAbs titers have been proposed in this study, all showing high efficacy.

TRANSFUSION (2021)

Add to Collection

Article Hematology

ABO blood group and SARS-CoV-2 antibody response in a convalescent donor population

Evan M. Bloch et al.

Summary: This study suggests that ABO blood group may influence the levels of neutralizing antibodies to SARS-CoV-2, with individuals with blood group B potentially having higher levels. Further research is needed to evaluate the relationship between ABO blood groups and antibody levels, along with the severity of COVID-19.

VOX SANGUINIS (2021)

Add to Collection

Article Immunology

Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China

Xia Feng et al.

Summary: The study found that antibody responses against SARS-CoV-2 dynamically change in patients, reaching a peak 5-8 weeks after symptom onset, with severe cases having higher levels of antibody responses and more inflammatory cells. In mild/moderate cases, there is a moderate association between the antibody responses, with the majority of cases achieving IgM and IgG seroconversion within 2 weeks of disease onset.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Virology

Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India

Kaustuv Nayak et al.

Summary: This study examined SARS-CoV-2 immune responses in COVID-19 recovered individuals from India, revealing that while most individuals had specific antibodies, only half had neutralizing antibodies. RBD-specific IgG levels were found to correlate with neutralizing antibody titers and memory B cell frequencies. These findings are important for plasma therapy donor selection and future vaccine evaluation efforts.

VIROLOGY (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Defining the Epidemiology of Covid-19-Studies Needed

Marc Lipsitch et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Virology

A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex

Fanfan Zeng et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Quan-Xin Long et al.

NATURE MEDICINE (2020)

Add to Collection

Article Medical Laboratory Technology

Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays

Mei San Tang et al.

CLINICAL CHEMISTRY (2020)

Add to Collection

Article Medicine, General & Internal

Humoral Immune Response to SARS-CoV-2 in Iceland

Daniel F. Gudbjartsson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Editorial Material Medicine, General & Internal

Dying in a Leadership Vacuum

[Anonymous]

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Immunology

Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients

Anita S. Iyer et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients

Baoqing Sun et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Review Immunology

Memory B cells: Effectors of long-lived immune responses

Stuart G. Tangye et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.